AI assistant
Vistin Pharma — Share Issue/Capital Change 2015
Jun 5, 2015
3782_iss_2015-06-05_4a9fb46c-898f-4974-904c-f8ef326e1a4b.html
Share Issue/Capital Change
Open in viewerOpens in your device viewer
Vistin Pharma ASA : Significantly oversubscribed offering in connection with the listing on Oslo Axess
Vistin Pharma ASA : Significantly oversubscribed offering in connection with the listing on Oslo Axess
NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, IN WHOLE OR IN PART DIRECTLY OR
INDIRECTLY, IN AUSTRALIA, CANADA, JAPAN OR THE UNITED STATES
Oslo, Norway, 5 June 2015
Vistin Pharma ASA (OSE: VISTIN), reference is made to the previous stock
exchange announcements regarding the sale of Weifa ASA's B2B business and tablet
production to Vistin Pharma AS, and the offering and listing on Oslo Axess of
17,054,935 new shares in Vistin Pharma ASA (the "Company") at a subscription
price of NOK 10.00 per share.
The subscription period in the Rights Offering and Employee Offering expired on
4 June 2015. Both tranches were significantly oversubscribed, resulting in gross
proceeds of NOK 170,549,350 through the issuance of 15,554,935 shares in the
Rights Offering and 1,500,000 shares in the Employee Offering.
Notifications of allocated new shares and the corresponding amount to be paid by
each subscriber will be sent to the subscribers today, 5 June 2015. Subscribers
having access to investor services through their VPS account will be able to
check the number of new shares allocated from 14:00 CET today. Subscribers may
also contact Carnegie at +47 22 00 93 64, from 14:00 CET today, to obtain
information about the number of new shares allotted. Payment for the allocated
new shares falls due on 9 June 2015.
Subject to payment being received when due, the new shares are expected to be
delivered to the respective subscribers' VPS account on or about 10 June 2015.
The new shares may not be transferred or traded until they are fully paid by the
individual subscriber.
The new shares are expected to commence trading on Oslo Axess on or about 10
June 2015.
Following the registration of the new share capital in the Norwegian Register of
Business Enterprises, and the simultaneous share capital reduction of the
1,000,000 existing shares in the Company owned by Weifa ASA, the Company will
have 17,054,935 shares outstanding, each with a par value of NOK 1.
For further information, please contact:
Kjell-Erik Nordby
CEO
+47 913 64 280
Gunnar Manum
CFO
+47 951 79 190
This information is subject to the disclosure requirements pursuant to section
5-12 of the Norwegian Securities Trading Act.
Important information:
The release is not for publication or distribution, in whole or in part directly
or indirectly, in or into Australia, Canada, Japan or the United States
(including its territories and possessions, any state of the United States and
the District of Columbia).
This release is an announcement issued pursuant to legal information
obligations, and is subject of the disclosure requirements pursuant to section
5-12 of the Norwegian Securities Trading Act. It is issued for information
purposes only, and does not constitute or form part of any offer or solicitation
to purchase or subscribe for securities, in the United States or in any other
jurisdiction. The securities mentioned herein have not been, and will not be,
registered under the United States Securities Act of 1933, as amended (the
"Securities Act"). The securities may not be offered or sold in the United
States except pursuant to an exemption from the registration requirements of the
Securities Act. The Company does not intend to register any portion of the
offering of the securities in the United States or to conduct a public offering
of the securities in the United States. Copies of this announcement are not
being made and may not be distributed or sent into Australia, Canada, Japan or
the United States. The issue, exercise, purchase or sale of subscription rights
and the subscription or purchase of shares in the Company are subject to
specific legal or regulatory restrictions in certain jurisdictions. Neither the
Company nor the Manager assumes any responsibility in the event there is a
violation by any person of such restrictions.
The distribution of this release may in certain jurisdictions be restricted by
law. Persons into whose possession this release comes should inform themselves
about and observe any such restrictions. Any failure to comply with these
restrictions may constitute a violation of the securities laws of any such
jurisdiction. Carnegie is acting for the Company and no one else in connection
with the Offering and will not be responsible to anyone other than the Company
for providing the protections afforded to their respective clients or for
providing advice in relation to the Offering and/or any other matter referred to
in this release.
***
[HUG#1926584]